Abstract
Background
There is scarcity of reports addressing patients with three or more malignancies. The aim of this study is to present a detailed analysis of patients presenting with at least three primary malignant tumors.
Patients and Methods
Records of cancer patients presenting to King Hussein Cancer Center (Amman, Jordan) between June 2006 and March 2011 were retrospectively reviewed. Patients harboring multiple primary tumors were included for detailed analysis. Data relating to epidemiological features, pathological characteristics, and disease outcomes were extracted.
Results
Out of 14,040 cases, 319 patients (2.3%) harbored two or more while 23 patients (0.16%) harbored three or more primary malignant tumors. This study included 17 males and six females between 4 and 78 years of age (median, 52 years) at the time of diagnosis of the first malignancy. The most prevalent tumor was colorectal adenocarcinoma found in nine, followed by lymphoma in seven, and prostate adenocarcinoma in six patients. The most common tumor combinations were colorectum–non-melanoma skin, colorectum–kidney, and non-melanoma skin–kidney all found in four patients, respectively. At a median follow-up of 96 months from the time of diagnosis of the first primary (range, 2–337 months) and 8 months from the time of diagnosis of the last primary (range, 1–48 months), 13 were alive with no evidence of disease, six were alive with residual disease, three were dead due to disease, and one patient was alive with unknown disease status.
Conclusions
The possibility of multiple primary malignancies should always be considered during the treatment and follow-up of cancer patients. This case series could prove helpful to clinicians faced with similar, however, exceedingly rare scenarios. Due to the realistic potential for long-term survival, we recommend aggressive treatment of these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Filali K, Hédelin G, Schaffer P, et al. Multiple primary cancers and estimation of the incidence rates and trends. Eur J Cancer. 1996;32A(4):683–90.
Koutsopoulos AV, Dambaki KI, Datseris G, Giannikaki E, Froudarakis M, Stathopoulos E. A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma—report of a case and review of the literature. World J Surg Oncol. 2005;3:51.
Rabbani F, Grimaldi G, Russo P. Multiple primary malignancies in renal cell carcinoma. J Urol. 1998;160(4):1255–9.
Thompson RH, Leibovich BC, Cheville JC, et al. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol. 2006;176(3):900–3. discussion 903–4.
Li H, Zhang Z, Shang L, Li X, Wang T. Carcinoma of the lung and multiple primary tumors. Chin Med J (Engl). 2000;113(9):799–801.
Rosso S, De Angelis R, Ciccolallo L, et al. Multiple tumours in survival estimates. Eur J Cancer. 2009;45(6):1080–94.
Feyerabend T, Richter E, Brandt A. Multiple malignomas—an analysis of 352 patients. Strahlenther Onkol. 1991;167(4):214–9. Article in German.
Bauer M, Zum Winkel K, Tempel M, Kempf B, Fritz P. Multiple cancers. Onkologie. 1984;7(3):156–66. Article in German.
Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol. 2001;27(3):302–13.
Németh Z, Czigner J, Iván L, Ujpál M, Barabás J, Szabó G. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49(6):412–4.
Sakashita H, Miyata M, Miyamoto H, Kurumaya H. A case of quadruple cancer, including triple cancers in the head and neck region. J Oral Maxillofac Surg. 1996;54(4):501–5.
Rennemo E, Zätterström U, Boysen M. Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy. Laryngoscope. 2011;121(2):304–9.
Hao SP. Four synchronous malignancies of the upper aerodigestive tract—management of an unusual case. Am J Otolaryngol. 1996;17(3):207–9.
Keshishian A, Sarkar FH, Kucyj G, Just-Viera JO. Four multiple primary malignant neoplasms of the aerodigestive tract. Ann Thorac Surg. 1998;65(1):252–4.
Beisland C, Talleraas O, Bakke A, Norstein J. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int. 2006;97(4):698–702.
Nutting C, Camplejohn RS, Gilchrist R, et al. A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy? Clin Oncol (R Coll Radiol). 2000;12(5):300–4.
Inskip PD. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer. Cancer. 2003;98(3):562–70.
Lee WS, Lee JN, Choi S, Jung M, Baek JH, Lee WK. Multiple primary malignancies involving colorectal cancer—clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg. 2010;395(4):359–64.
Hao SP. Six primary squamous cell carcinomas of the head and neck. Auris Nasus Larynx. 1998;25(1):101–4.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salem, A., Abu-Hijlih, R., Abdelrahman, F. et al. Multiple Primary Malignancies: Analysis of 23 Patients with at Least Three Tumors. J Gastrointest Canc 43, 437–443 (2012). https://doi.org/10.1007/s12029-011-9296-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-011-9296-7